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Abstract
Objective. To identify quality measures for international benchmarking of mental health care that assess important processes
and outcomes of care, are scientifically sound, and are feasible to construct from preexisting data.
Design. An international expert panel employed a consensus development process to select important, sound, and feasible
measures based on a framework that balances these priorities with the additional goal of assessing the breadth of mental health
care across key dimensions.
Participants. Six countries and one international organization nominated seven panelists consisting of mental health adminis-
trators, clinicians, and services researchers with expertise in quality of care, epidemiology, public health, and public policy.
Measures. Measures with a final median score of at least 7.0 for both importance and soundness, and data availability rated as
‘possible’ or better in at least half of participating countries, were included in the final set. Measures with median scores ≤3.0 or
data availability rated as ‘unlikely’ were excluded. Measures with intermediate scores were subject to further discussion by the
panel, leading to their adoption or rejection on a case-by-case basis.
Results. From an initial set of 134 candidate measures, the panel identified 12 measures that achieved moderate to high scores
on desired attributes.
Conclusions. Although limited, the proposed measure set provides a starting point for international benchmarking of mental
health care. It addresses known quality problems and achieves some breadth across diverse dimensions of mental health care.
Keywords: benchmarking, consensus development, international, mental health, quality measures
Background
Mental health and substance-related disorders are prevalent, dis-
abling, and costly. An estimated 450 million people worldwide
are affected by mental, neurological, or behavioral problems at
any given time, and studies indicate that approximately one in
five will experience a psychiatric disorder within a given year [1].
A World Health Organization (WHO) study found these condi-
tions to account for almost 11% of the global burden of disease
in 1990. Among the 10 leading causes of disability worldwide, 5
are psychiatric conditions—depression, bipolar disorder, schiz-
ophrenia, obsessive–compulsive disorder, and alcohol abuse [2].
The percentage of annual health care expenditures spent
on mental health care varies widely, exceeding 20% among
the highest spending nations [1]. Furthermore, mental health
and substance-related disorders incur large indirect costs in
utilization of other medical services, in lost work productivity,
and in the burden on families and other caregivers. Effective
medication and psychosocial treatments exist for many men-
tal disorders [3]. However, research studies have documented
wide variations in the quality of care including gaps between
clinical practice and evidence-based guideline recommenda-
tions [4]. These findings have led to widespread attention to
improving the quality of mental health care [5–9].
In this issue of the journal, Mattke et al. [10] describe the
potential utility of measurement-based quality improvement
and international comparisons of measure results. Data on key
processes and outcomes of care can facilitate improvement
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within organizations delivering care, provide oversight of
quality by public agencies and private payers, and provide
insight into what levels of performance are feasible. These
activities require robust measures that permit meaningful
comparisons across providers, systems, or geographic
regions. In many areas of health care, however, there is a lack
of agreement on which measures should be used. In mental
health care, the challenges are to some extent even greater—
the diverse nature of the field and competing priorities among
stakeholders have slowed consensus development on a core
set of measures for common use [4]. Despite these limita-
tions, several countries have implemented measures to evalu-
ate mental health care [11–22].
The Organization for Economic and Community Devel-
opment’s Health Care Quality Indicators Project (OECD–
HCQI) is the first effort of which we are aware to identify
measures for international benchmarking of quality of mental
health care. This article reports on the methods employed to
develop consensus among participants along with the result-
ing measures, as well as challenges to be surmounted for
further progress to be achieved.
Methods
We conducted a consensus development process with a panel
of international experts drawing on established procedures
and based on a framework for quality-measure selection. The
consensus development process employed elements of the
modified Delphi method, because it has been applied to selec-
tion of quality measures [23,24]. The panelists’ evaluation was
conducted over two phases. In the first phase, each panelist
anonymously rated measures on numerical scales for import-
ance, soundness, and feasibility. The results were used to
identify measures with sufficient consensus for inclusion or
exclusion. For measures where consensus was lacking, the
panel conducted a second review, making decisions about
inclusion/exclusion on a case-by-case basis.
Our framework [25] reflects the twin—and in some
respects conflicting—goals of measure selection. In selecting
quality measures, organizations typically seek to maximize
desirable measure attributes, which the OECD–HCQI char-
acterizes as: importance, scientific soundness, and feasibility.
But organizations also typically seek measures that are repre-
sentative of highly diverse health care systems. Dimensions of
this diversity include domains of quality (e.g. prevention,
access, assessment, treatment, continuity, coordination, safety,
and outcomes). They also include breadth among clinical
disorders (emphasizing conditions with high prevalence,
morbidity, and treatability), treatment modalities (both medi-
cation and psychosocial variation), clinical settings across the
continuum of care, and vulnerable subpopulations including
children, the elderly, and racial/ethnic minorities. Complicat-
ing the process of measure selection are tensions among these
goals. Clinically important, evidence-based measures typically
require richer, more costly data sources [26]—thus, more
important measures may be less feasible to implement. Meas-
ures of mental health care for children are at an earlier stage
of development and testing than measures for adults—thus,
broader representativeness may conflict with scientific sound-
ness. These examples illustrate trade-offs in measure selection
that our framework helps to make explicit and addressable [25].
In response to a call for participation from the OECD
Secretariat six countries (United Kingdom, Sweden, Canada,
Australia, Denmark, and the United States) and one interna-
tional organization, the European Society for Quality in
Healthcare (ESQH) nominated seven panelists. Panel mem-
bers included mental health administrators, clinicians, and
services researchers with expertise in quality of care, epidemi-
ology, public health, and public policy. Additionally, each
panelist had experience in the development of national core
sets of quality measures for mental health care.
The seven panelists participated in a multistage consensus
development process (Figure 1). Firstly, panelists identified
and reviewed 134 measures of care for mental health and
substance-use disorders (the candidate set). Indicators were
drawn from OECD member countries’ initiatives, conducted
by national health departments, payers, accreditors, research-
ers, and other stakeholder organizations. Specific sources
included the Canadian Mental Health Advisory Network, the
United Kingdom Department of Health, the Center for
Quality Assessment and Improvement in Mental Health’s
National Inventory of Mental Health Quality Measures,
numerous US stakeholder initiatives, and published research
reports. Information about these sources is detailed in the
report, Selecting Indicators for the Quality of Mental Health
Care at the Health Systems Level in OECD Countries [27].
The 134 candidate measures were screened against the cri-
teria established by the OECD Secretariat to identify mea-
sures appropriate for international benchmarking [28]. The
criteria sought to establish a conceptual focus, standardized
methods, and a preliminary, achievable goal that would serve
as a foundation for future work. For inclusion in the candid-
ate set, measures had to meet each of the following:
• Indicators focusing on quality (as opposed to cost or
utilization).
• Indicators relevant to assessing quality at the system level.
• Indicators focusing on technical (rather than interper-
sonal) quality.
• Indicators constructed from pre-existing administrative
data based on standardized coding.
• Single item indicators (rather than multi-item scales).
Of the candidate measures, 23 met screening criteria (the
screened set). These measures, accompanied by information on
their specifications and data sources, were reviewed and rated
by the panel using a structured assessment process. Each
measure was rated anonymously on 9-point Likert scales for
indicator importance and scientific soundness. In rating
importance, panelists were asked to consider import to policy,
impact on health, and susceptibility to being influenced by the
health care system. In rating scientific soundness, panelists
were asked to consider face validity, content validity, and
explicitness of the evidence base. Each panelist also rated the
feasibility of data collection in his or her country as likely,
possible, or unlikely for each measure. Ratings were obtained
from five panelists (all but representatives from Denmark and
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ESQH); all seven panelists participated in discussions preced-
ing and subsequent to the rating process.
In developing decision rules for inclusion/exclusion of
measures, we adopted the approach used in the RAND
appropriateness method [29]: 9–7 indicating agreement, 6–4
neither agreement nor disagreement, and 3–1 disagreement.
To derive a preliminary set, we included measures that [1] had a
median score ≥7 for both importance and soundness and [2]
more than half of participating panelists reported that data
availability for the indicator was either ‘possible’ or ‘likely’.
Excluded from this preliminary set were measures that had a
median score ≤3 for either importance or soundness or half or
more participating panelists reported that data availability was
‘unlikely’.
The remaining measures—with importance and soundness
scores between 4 and 7 as well as more than half of panelists
reporting data availability to be at least ‘possible’—were
returned to the panel for a second round of review. Each
measure was discussed further with regard to their merit and
their contribution to the breadth of topics addressed. Inclu-
sion/exclusion decisions were then made on a case-by-case
basis by consensus. The resulting recommended set was for-
warded to the OECD–HCQI Steering Committee for their
consideration.
Results
Of the initial 134 candidate set measures, only 23 (17%) met the
specified screening criteria and were rated by the expert panel.
Of the 23 measures meeting screening criteria, 4 received
ratings meeting the inclusion criteria for the preliminary set, 4
met exclusion criteria, and 15 with intermediate ratings were
forwarded to the panel for further review. Panelists discussed
the strengths and weaknesses of the measures receiving inter-
mediate ratings along with their relative contribution to a
broad and balanced measure set. Consensus was achieved on
including 8 of the 15 measures in the final, recommended set, for
12 measures.
Table 1 demonstrates the influence of each stage of the
selection process on the diversity of the resulting measure
sets. In proceeding from the candidate measure set to the
criteria-based preliminary set, the number of quality domains
represented by the resulting measure set decreased from eight
to two, diagnostic groups categories from six to three, treat-
ment modalities from five to one, and vulnerable populations
from five to one. In the subsequent phase of the selection
process, panelists noted what they regarded as important gaps
among the subjects of these measures and identified what
they considered ‘good enough’ measures among those with
intermediate scores to fill these gaps. This phase resulted in
an expansion in the number of measures within in each
dimension in the final, recommended measure set to four
quality domains, three diagnostic groups, four treatment
modalities, and four vulnerable populations.
Table 2 describes the measures in the recommended set
and their rating scores. The mean importance score for the set
was 6.66, and the mean score for scientific soundness was
6.21. Data availability was assessed as ‘likely’ or ‘possible’ by
all five panelists for seven measures and by four of the five
panelists for the other five measures. Minor revisions were
made to the recommended measures to refine specifications
and eliminate redundancy.
Discussion
The 12 indicators recommended by the Mental Health Panel
assess clinically important processes and outcomes of care
Figure 1 Measure selection process.
Identified 134 candidate measures from
OECD member countries
Excluded 111 measures
Not focused on technical quality
Not single-item indicators
Not system level
Not based on administrative data
23 measures rated by expert panel
4 measures met inclusion criteria
4 measures met exclusion criteria
15 measures with intermediate ratings
Measures with intermediate ratings reviewed by panel;
8 of 15 included by consensus
12 indicators recommended to
OECD HCQI Steering Committee
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where there is known variation in the quality of clinical prac-
tice. The measures, selected by an international expert panel
using a structured process, represent progress toward the goal
of identifying consensus-based measures for international
benchmarking of mental health care. This is only a step in a
longer-term process, however, as noted by the measures’
moderate ratings on importance, scientific soundness, and
feasibility. Information on these measures—including their
clinical rationale, basis in research evidence, specifications,
prior results, and testing—can be found in the OECD report
and detailed review of measures [4,27].
The selection process achieved some degree of success
toward the objective of selecting a measure set reflecting the
diversity of mental health systems. The majority of the mea-
sures are applicable across diagnostic categories, whereas five
evaluate care specific to depression and substance-use disor-
ders—conditions of high prevalence, morbidity, and treatabil-
ity. The measures evaluate several domains of quality,
including treatment, continuity, coordination, and outcome.
They assess several modalities of treatment, including medica-
tion management, psychotherapy, and case management.
They evaluate care in both in-patient and outpatient settings,
as well as care for vulnerable subgroups such as elderly
patients and racial/ethnic minorities.
Limited to measures previously implemented within
OECD member countries and constructible from pre-existing
administrative data sets, the resulting measure set also has
significant gaps. Hundreds of quality measures have been pro-
posed for mental health care; however, a US study found wide
variability in their evidence base, operational development,
Table 1 Characteristics of initial, screened, and recommended indicators
...................................................................................................................................
Indicator set
Candidate set 
(n = 134)
Screened set 
(n = 23)
Preliminary set 
(n = 4)
Recommended 
set (n = 12)
............................................................................................................................................................................................................................
Quality domain
Process 113 18 4 11
Treatment 43 12 2 6
Continuity 11 4 2 4
Coordination 4 2 0 1
Safety 23 0 0 0
Assessment 18 0 0 0
Prevention 0 0 0 0
Access 0 0 0 0
Other 14 0 0 0
Outcome 21 5 0 1
Clinical conditions
Across diagnoses 84 13 2 7
Depressive disorders 38 6 1 3
Schizophrenia/Other psychotic disorders 5 1 0 0
Substance-related disorders 3 1 1 2
Bipolar disorder 1 1 0 0
Borderline personality disorder 1 1 0 0
Treatment modalities
Medication 20 5 1 3
Case management 3 2 0 1
Psychotherapy 2 1 0 1
Electroconvulsive Therapy (ECT) 2 0 0 0
Other 2 2 0 1
Vulnerable populations
Elderly 18 3 0 1
Severe persistent mental illness 17 2 0 1
Children/adolescents 2 0 0 0
Racial/ethnic minorities 1 1 0 1
Dual diagnosis MH/SA 2 1 1 1
Settings
Outpatient 44 13 3 8
In-patient 42 4 1 1
Unspecified 48 6 0 3
 at Sim
on Fraser U
niversity on February 28, 2013
http://intqhc.oxfordjournals.org/
D
ow
nloaded from
 
Quality indicators
35
Table 2 Ratings for recommended mental health and substance-related quality indicators
Name Description Importance 
median
Soundness 
median ..........................................................
Data availability (n = 5 panelists)
Unlikely Possible Likely
................................................ ................................................................. ......................... ....................... ........................ ................... ..............
Treatment
Visits during acute 
phase treatment 
of depression
% of persons with a new diagnosis 
of major depression who receive 
at least three medication visits or 
at least eight psychotherapy visits in 
a 12-week period [34].
7.00 7.50 1 2 2
Hospital readmissions 
for psychiatric patients
% of discharges from psychiatric 
in-patient care during a 12-month 
reporting period readmitted to 
psychiatric in-patient care that 
occurred within 7 and 30 days [12].
7.00 7.00 0 0 5
Length of treatment for 
substance-related 
disorders
% of persons initiating treatment 
for a substance-related disorder 
with treatment lasting at least 90 
days [35].
6.00 6.50 0 3 2
Use of anticholinergic 
antidepressant drugs 
among elderly patients
% of persons age 65+ years 
prescribed antidepressants using 
an anticholinergic anti-depressant 
drug [36].
6.00 6.00 1 2 2
Continuous 
antidepressant 
medication treatment in 
acute phase
% of persons age ≥18 years who are 
diagnosed with a new episode of 
depression and treated with 
antidepressant medication, with an 
84-day (12-week acute treatment 
phase) treatment with 
antidepressant medication [15,37].
6.00 4.00 1 2 2
Continuous 
antidepressant 
medication treatment in 
continuation phase
% of persons age ≥18 years who are 
diagnosed with a new episode of 
depression and treated with 
antidepressant medication, with a 
180-day treatment of antidepressant 
medication [15,37].
6.00 4.00 1 2 2
Continuity
Timely ambulatory 
follow-up after mental 
health hospitalization
% of persons hospitalized for 
primary mental health diagnoses 
with an ambulatory mental health 
encounter with a mental health 
practitioner within 7 and 30 days of 
discharge [12].
8.00 7.00 0 1 4
Continuity of visits after 
hospitalization for dual 
psychiatric/ substance-
related conditions
% of persons discharged with a dual 
diagnosis of psychiatric disorder 
and substance abuse with at least 
four psychiatric and at least four 
substance abuse visits within the 12 
months after discharge [38].
7.00 7.00 0 3 2
Racial/ethnic disparities 
in mental health follow-
up rates
% of persons with a mental health-
related visit receiving at least one 
visit in 12 months after initial visit 
stratified by race/ethnicity [18].
7.00 6.50 0 3 2
continued
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validity and reliability, and adequacy of case mix adjustment
[4,26]. Table 1 demonstrates the implications of these find-
ings for this project—namely the loss of diversity among
measure topics as standards for importance, soundness and
feasibility are applied. The recommended measure set lacks
indicators of prevention, access, assessment, and safety of
care. Although several measures could be meaningfully strati-
fied by age, the set does not include measures specific to chil-
dren’s mental health services. Common comorbidities of
mental illness—including substance-use disorders and med-
ical conditions—are only indirectly addressed. Measures were
not available to assess emergent care or services at intermediate
levels of care, such as residential or partial programs. The
medication measures examine appropriateness of care more
effectively than the measures of psychosocial interventions
such as therapy or case management. A contributing factor is
that administrative data provide more detailed information
about medication management (e.g. dose, duration, and inten-
sity) than about the content of psychosocial treatments.
These challenges have been encountered in other initiatives
that have sought to identify measures based on administrative
data [30]. They are intensified here by the further restriction
to data available on a comparable basis across several countries.
Limitations to this study include the number of participants
(seven individuals from six countries and one international
organization). Panelists did have a unique depth of experience,
each previously having participated in one or more national or
international consensus development processes on this topic.
The generalizability of the results may be limited to developed
countries, because developing countries struggle with the ade-
quacy of their data systems in addition to their systems of men-
tal health care. The WHO has developed the WHO Assessment
Instrument for Mental Health Systems (WHO–AIMS) to sup-
port quality assessment and planning in low- and middle-income
countries lacking robust systems for administrative data [31].
It should additionally be noted that measures of rate-based
processes and outcomes represent a subset of a broader range
of approaches to quality assessment in mental health care.
Other methods providing essential insights include: (i) evaluation
of patient perceptions of care, (ii) measurement of clinical
outcomes, such as change in symptoms, functioning, or qual-
ity of life, and (iii) assessment of the fidelity of evidence-based
interventions to their empirically proven models. There has
been little standardized implementation of such instruments
either within or between nations [32].
Progress from this point forward is likely to be incremental
and iterative. First, this measure set will need refinement as
the OECD further investigates the availability of required
data elements among countries participating in the bench-
marking initiative. Secondly, pilot implementation of these
measures would provide data allowing for measure testing
and development of case mix adjustment. Thirdly, the meas-
ure of life expectancy among individuals with severe mental
illness illustrates the potential for linkage among data sources
to contribute to the development of meaningful quality mea-
sures. The indicator reflects research findings that individuals
with severe mental illness die at a younger age than members
of the general population and that better detection and gen-
eral medical care for these individuals could contribute to nar-
rowing this gap [33]. The OECD plans to further explore the
ability of member countries to link national health care and
mortality data sets. Analogous linkages may present opportu-
nities to examine educational or criminal-justice outcomes of
mental health care. Fourthly, these initial efforts at consensus
development should be built upon by identifying key clinical
variables that, if added to existing administrative data systems,
would allow for measurement of important clinical processes.
A more extensive but crucial undertaking is developing con-
sensus nationally and internationally on standardized meth-
ods for structured assessment of clinical diagnoses, symptom
severity, and functional impairment as well as on tools to
evaluate patient experiences and treatment fidelity.
In the meantime, the measure set recommended herein
provides a starting point for international benchmarking of
mental health care. It covers several relevant dimensions of
care and addresses known variations in important processes
Table 2 continued
Continuity of visits after 
mental health-related 
hospitalization
% of persons hospitalized for 
psychiatric or substance-related 
disorder with at least one visit per 
month for 6 months after 
hospitalization [39].
6.00 6.00 0 1 4
Coordination
Case management for 
severe psychiatric 
disorders
% of persons with a specified 
severe psychiatric disorder in 
contact with the health care system 
who receive case management (all 
types) [12].
7.00 6.50 0 4 1
Outcome
Mortality for persons 
with severe psychiatric 
disorders
Standardized mortality rate for % of 
persons in total population with 
specified severe psychiatric 
disorders [12].
7.00 6.50 1 2 2
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and outcomes. Although much work will be needed to refine,
specify, implement, and augment these measures, they pro-
vide a foundation for further progress.
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